weight regain after stopping glp-1 agonists Ozempic, Wegovy & Mounjaro: What to Know obesity #glp1 #treatmentcessation #weightregain #glp1receptoragonist
Description
This can lead to surprise increased cost for medications
Obesity arises from an imbalance between energy intake and expenditure, and this relationship can be summarized as the energy balance-feedback model, which provides the basis for drug treatment
Open-label studies, case reports, and studies based solely on correlation data were excluded to ensure recommendations were grounded in robust clinical evidence
A series of (4-substituted prolyl) prolinenitriles as DPP-4 inhibitors were evaluated in a study by Kondo and coworkers (127)
